These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 29163050)

  • 1. Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection.
    Sheth S; Mukherjea D; Rybak LP; Ramkumar V
    Front Cell Neurosci; 2017; 11():338. PubMed ID: 29163050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
    Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
    J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient Receptor Potential Channels and Auditory Functions.
    Ramkumar V; Sheth S; Dhukhwa A; Al Aameri R; Rybak L; Mukherjea D
    Antioxid Redox Signal; 2022 Jun; 36(16-18):1158-1170. PubMed ID: 34465184
    [No Abstract]   [Full Text] [Related]  

  • 4. Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.
    Mukherjea D; Jajoo S; Whitworth C; Bunch JR; Turner JG; Rybak LP; Ramkumar V
    J Neurosci; 2008 Dec; 28(49):13056-65. PubMed ID: 19052196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Cisplatin-Induced Ototoxicity and Prevention.
    Rybak LP; Mukherjea D; Ramkumar V
    Semin Hear; 2019 May; 40(2):197-204. PubMed ID: 31036996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.
    Borse V; Al Aameri RFH; Sheehan K; Sheth S; Kaur T; Mukherjea D; Tupal S; Lowy M; Ghosh S; Dhukhwa A; Bhatta P; Rybak LP; Ramkumar V
    Cell Death Dis; 2017 Jul; 8(7):e2921. PubMed ID: 28703809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
    Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
    Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea.
    Bhatta P; Dhukhwa A; Sheehan K; Al Aameri RFH; Borse V; Ghosh S; Sheth S; Mamillapalli C; Rybak L; Ramkumar V; Mukherjea D
    Sci Rep; 2019 Mar; 9(1):4131. PubMed ID: 30858408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity.
    Ramkumar V; Mukherjea D; Dhukhwa A; Rybak LP
    Antioxidants (Basel); 2021 Nov; 10(12):. PubMed ID: 34943021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
    Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
    Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-induced ototoxicity: From signaling network to therapeutic targets.
    Wang X; Zhou Y; Wang D; Wang Y; Zhou Z; Ma X; Liu X; Dong Y
    Biomed Pharmacother; 2023 Jan; 157():114045. PubMed ID: 36455457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
    Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
    Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Otoprotection against aminoglycoside- and cisplatin-induced ototoxicity focusing on the upstream drug uptake pathway.
    Hsieh CY; Tsai CY; Chou YF; Hsu CJ; Wu HP; Wu CC
    J Chin Med Assoc; 2024 Jan; 87(1):17-24. PubMed ID: 37962398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity.
    Gu J; Wang X; Chen Y; Xu K; Yu D; Wu H
    J Nanobiotechnology; 2022 Jun; 20(1):268. PubMed ID: 35689218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss.
    Mukherjea D; Jajoo S; Sheehan K; Kaur T; Sheth S; Bunch J; Perro C; Rybak LP; Ramkumar V
    Antioxid Redox Signal; 2011 Mar; 14(6):999-1010. PubMed ID: 20712533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity.
    Al Aameri RFH; Alanisi EMA; Oluwatosin A; Al Sallami D; Sheth S; Alberts I; Patel S; Rybak LP; Ramkumar V
    Front Immunol; 2023; 14():1125948. PubMed ID: 37063917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of 1,2,3-triazole derivative KPR-A020 against cisplatin-induced ototoxicity in murine cochlear cultures.
    Kim YR; Jung DJ; Oh SK; Lee T; Lee IK; Lee KY; Kim UK
    Int J Pediatr Otorhinolaryngol; 2017 May; 96():59-64. PubMed ID: 28390615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Mechanisms of Antioxidant Compounds and Combinations Thereof against Cisplatin-Induced Hearing Loss in a Rat Model.
    Carles L; Gibaja A; Scheper V; Alvarado JC; Almodovar C; Lenarz T; Juiz JM
    Antioxidants (Basel); 2024 Jun; 13(7):. PubMed ID: 39061830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria-Targeted Antioxidants for Treatment of Hearing Loss: A Systematic Review.
    Fujimoto C; Yamasoba T
    Antioxidants (Basel); 2019 Apr; 8(4):. PubMed ID: 31022870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin Chemotherapy and Cochlear Damage: Otoprotective and Chemosensitization Properties of Polyphenols.
    Fetoni AR; Paciello F; Troiani D
    Antioxid Redox Signal; 2022 Jun; 36(16-18):1229-1245. PubMed ID: 34731023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.